The Study of the Combination of Thiotepa and Pomalidomide for the Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma Patients.
Condition: Relapsed or Refractory (R/R) Primary Central Nervous System Lymphoma Intervention: Drug: thiotepa combined with pomalidomide Sponsor: The First Affiliated Hospital with Nanjing Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials